Universe Pharmaceuticals (UPC) Debt Ratio (2021 - 2026)

Universe Pharmaceuticals (UPC) posted Debt Ratio of 0.13 for Q1 2026, up 29.57% sequentially from 0.1 in Q3 2025.

Universe Pharmaceuticals (UPC) Debt Ratio (2021 - 2026) Analysis & Trends

Universe Pharmaceuticals has reported Debt Ratio for 6 years, with the latest figure at 0.13 in Q1 2026.

Quarterly Debt Ratio changed N/A year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.13 (changed N/A YoY) and the FY2025 annual result came in at 0.1, down 12.3% from the prior year.
Debt Ratio grew to 0.13 in Q1 2026 per UPC's latest filing, from 0.1 in the prior quarter.
Over five years, Debt Ratio peaked at 0.13 in Q1 2026 and troughed at 0.04 in Q1 2024.
A 5-year average of 0.09 and a median of 0.1 in 2025 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2022 and 2025: Debt Ratio surged 20085.36% in 2022, then decreased 12.3% in 2025.
Over 5 years, Debt Ratio stood at 0.06 in 2022, then soared by 131.51% to 0.13 in 2023, then retreated by 10.47% to 0.12 in 2024, then retreated by 12.3% to 0.1 in 2025, then gained by 29.57% to 0.13 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.13, 0.1, and 0.12 for Q1 2026, Q3 2025, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-0.13
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	0.42
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.32
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	0.12
10	Universe Pharmaceuticals	3.04 Mn	-26.01 Mn	-	0.13

Download Data